ABSTRACT
Modern cancer treatments for abdominopelvic malignancies have rapidly evolved towards precision therapy, becoming increasingly personalized by focusing on the molecular profile of tumours. Surgery, radiotherapy and chemotherapy, including newer targeted therapies and whether used alone or in combination, are all associated with at least some level of undesired toxicity.
